MAPT and Alzheimer disease: Along these lines, a so-called “biological” perspective of AD, convened by the U.S. National Institute of Aging and formulated by the Alzheimer’s Association Workgroup, relies on the underlying abnormal, pathological findings: Aβ deposition, pathological tau protein, and neurodegeneration (Jack et al., 2018).